Human Cyclophilin-F Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Human Cyclophilin-F antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Human Cyclophilin-F |
| Clone | [PAT1F5AT] |
| Host Species | Mouse |
| Reactive Species | n/a |
| Isotype | IgG2b k |
| Format | Protein G purified |
| Size | 0.005 mg, 0.02 mg, 0.1 mg |
| Concentration | n/a |
| Applications | ELISA (EIA), Western Blot (WB), Immunohistochemistry (IHC) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Introduction: PPIF is a part of the peptidyl-prolyl cis-trans isomerase (PPIase) family. PPIF accelerates the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. PPIF is key component of the mitochondrial permeability transition pore in the inner mitochondrial membrane. Activation of this pore is thought to be involved in the induction of apoptotic and necrotic cell death. |
| Immunogen | Immunogen: Anti-human Cyclophilin-F mAb is derived from hybridization of mouse F0 myeloma cells with spleen cells from BALB/c mice immunized with recombinant human Cyclophilin-F amino acids 30-207 purified from E Coli. |
| Other Names | [PPIF; Cyclophilin-F, Mouse Human; Oeptidylprolyl Isomerase F; PPIF; CYP-D; CYP3; SnuCyp-20; Peptidyl-prolyl cis-trans isomerase mitochondrial; Cyclophilin F; FLJ90798; MGC117207; peptidylprolyl isomerase F], [PPIF; PPIF; CYP3; CypD; CyP-M; Cyp-D; CYP3; PPIase F; CyP-D; CypD; CyP-M] |
| Gene, Accession # | [PPIF], Gene ID: 10105, NCBI: NP_005720.1 |
| Catalog # | MBS140240 |
| Price | $140, $205, $505 |
| Order / More Info | Human Cyclophilin-F Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies